Although this medication is usually well-tolerated, tell your doctor about any allergies, medical conditions, medications, and supplements you take
Back Villumsen, M, Schelde, AB Jimenez-Solem, E (July 2021) 'GLP-1 based therapies and disease course of inflammatory bowel disease', eClinical Medicine, 37/100979
When should I call my doctor about GLP-1 nausea
The Question of Thyroid Cancer The warning in patient leaflets regarding thyroid C-cell tumours stems from early rodent studies
A prospective study to evaluate the efficacy and safety of vitamin E and levocarnitine prophylaxis against doxorubicin-induced cardiotoxicity in adult breast cancer patients
While many of these molecules showed promising results in preclinical rodent, minipig, or non-human primate (NHP) models, they could not achieve sufficient therapeutic windows to observe clinical weight loss without adverse events such as cardiac activation ( MK-0493 MK-0493 is an orally available small molecule developed by Merck ( Figure 2 )